Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-07-05T15:14:51.225Z Has data issue: false hasContentIssue false

28 - Clonazepam

Published online by Cambridge University Press:  06 October 2020

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan
Affiliation:
Thomas Jefferson University, Philadelphia
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

THERAPEUTICS

Brands

• Klonopin, Rivotril

Generic?

• Yes

Class

• Benzodiazepine, antiepileptic drug (AED)

Commonly Prescribed for

(FDA approved in bold)

Seizure disorders. Used as monotherapy or adjunctive for the treatment of Lennox- Gastaut syndrome, akinetic, myoclonic, or absence seizures

Panic disorder, with or without agoraphobia

• Periodic leg movements disorder (PLMD)

• Restless legs syndrome (RLS)

• Tic disorders

• Parkinsonian (hypokinetic) dysarthria

• Tardive dyskinesia

• Muscle relaxation

• Insomnia

• Burning mouth syndrome

• Generalized anxiety disorder

• Schizophrenia (adjunctive)

• Acute mania in bipolar disorder

How the Drug Works

• Benzodiazepines bind to and potentiate the effect of GABAA receptors, which are ligandgated chloride channels activated by GABA. It boosts chloride conductance across cell membranes, hyperpolarizes the membrane potential, and increases the threshold potential. There are at least 2 benzodiazepine receptors, 1 of which is associated with sleep mechanisms, the other with memory, sensory, and cognitive functions. Benzodiazepines act at spinal cord, brainstem, cerebellum, limbic, and cortical areas

• In petit mal seizures clonazepam suppresses spike and wave discharges, and in motor seizures decreases the frequency, amplitude, duration, and spread of discharge

How Long Until It Works

• There is often an immediate effect in treatment of epilepsy, PLMD, RLS, insomnia, and panic disorders, but usually weeks are required for optimal dose adjustments and maximal therapeutic benefit

If It Works

• Seizures: goal is the remission of seizures. Continue as long as effective and well tolerated. Consider tapering and slowly stopping after 2 years seizure-free, depending on the type of epilepsy

• PLMD, RLS, tic disorders: continue to adjust dose to find the lowest dose that produces relief of symptoms with fewest AEs

• Anxiety: often used only on a short-term basis. Consider adding an SSRI or SNRI for long-term treatment

If It Doesn't Work

• Epilepsy: consider changing to another agent, adding a second agent, using a medical device, or a referral for epilepsy surgery evaluation. When adding a second agent, keep drug interactions in mind

Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 102 - 105
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Clonazepam
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.029
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Clonazepam
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.029
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Clonazepam
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.029
Available formats
×